In this context, our data suggest that one mechanism for RAS-mutant cancers to avoid excess signaling and senescence is to concurrently repress FAXDC2, thereby preventing RTK hyperactivation and inhibiting downstream MAPK signaling. Here, FAXDC2 is linked to cancer.